The cycling of acetyl-coenzyme A through acetylcarnitine buffers cardiac substrate supply: A hyperpolarized 13C magnetic resonance study

Circulation: Cardiovascular Imaging

Volumn 5, Issue 2, 2012, Pages 201-209

  Schroeder, Marie A ^a   Atherton, Helen J ^a   Dodd, Michael S ^a   Lee, Phillip ^a   Cochlin, Lowri E ^a   Radda, George K ^a   Clarke, Kieran ^a   Tyler, Damian J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Acetylcarnitine; Imaging; Magnetic resonance spectroscopy; Metabolism

Indexed keywords

ACETYL COENZYME A; ACETYLCARNITINE; CARBOHYDRATE; CARNITINE ACETYLTRANSFERASE; CITRIC ACID; DICHLOROACETIC ACID; DOBUTAMINE; GADOTERATE MEGLUMINE; GLUTAMIC ACID; PYRUVATE DEHYDROGENASE; PYRUVIC ACID; CARBON; PYRUVATE DEHYDROGENASE COMPLEX;

ANIMAL EXPERIMENT; ARTICLE; CARBOHYDRATE OXIDATION; CARBON NUCLEAR MAGNETIC RESONANCE; CONTROLLED STUDY; EX VIVO STUDY; HEART; IN VIVO STUDY; MALE; NONHUMAN; OXIDATION; PRIORITY JOURNAL; RADIOFREQUENCY; RAT; ANIMAL; ENERGY METABOLISM; ENZYMOLOGY; HEART CONTRACTION; HEART MUSCLE; METABOLISM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OXIDATION REDUCTION REACTION; POSTPRANDIAL STATE; TIME; WISTAR RAT;

ACETYL COENZYME A; ACETYLCARNITINE; ANIMALS; CARBON ISOTOPES; CARNITINE O-ACETYLTRANSFERASE; CITRIC ACID; ENERGY METABOLISM; GLUTAMIC ACID; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MYOCARDIAL CONTRACTION; MYOCARDIUM; OXIDATION-REDUCTION; POSTPRANDIAL PERIOD; PYRUVATE DEHYDROGENASE COMPLEX; PYRUVIC ACID; RATS; RATS, WISTAR; TIME FACTORS;

EID: 84860787353     PISSN: 19419651     EISSN: 19420080     Source Type: Journal    
DOI: 10.1161/CIRCIMAGING.111.969451     Document Type: Article

References (42)

1. Linn TC, Pettit FH, Reed LJ. Alpha-keto acid dehydrogenase complexes. X. Regulation of the activity of the pyruvate dehydrogenase complex from beef kidney mitochondria by phosphorylation and dephosphorylation. Proc Natl Acad Sci U S A. 1969;62:234-241.
2. Hansford RG, Cohen L. Relative importance of pyruvate dehydrogenase interconversion and feed-back inhibition in the effect of fatty acids on pyruvate oxidation by rat heart mitochondria. Arch Biochem Biophys. 1978;191:65-81. (Pubitemid 9050309)
3. Collins-Nakai RL, Noseworthy D, Lopaschuk GD. Epinephrine increases ATP production in hearts by preferentially increasing glucose metabolism. Am J Physiol. 1994;267:H1862-H1871.
4. Owen OE, Mozzoli MA, Boden G, Patel MS, Reichard GA Jr, Trapp V, Shuman CR, Felig P. Substrate, hormone, and temperature responses in males and females to a common breakfast. Metabolism. 1980;29: 511-523. (Pubitemid 10123239)
5. Cross HR, Opie LH, Radda GK, Clarke K. Is a high glycogen content beneficial or detrimental to the ischemic rat heart? A controversy resolved. Circ Res. 1996;78:482-491.
6. Saddik M, Lopaschuk GD. Myocardial triglyceride turnover and contribution to energy substrate utilization in isolated working rat hearts. J Biolog Chem. 1991;266:8162-8170. (Pubitemid 21906491)
7. Kreisberg RA. Effect of diabetes and starvation on myocardial triglyceride and free fatty acid utilization. Am J Physiol. 1966;210:379-384.
8. Kreisberg RA. Effect of epinephrine on myocardial triglyceride and free fatty acid utilization. Am J Physiol.1966;210:385-389.
9. Neubauer S. The failing heart-an engine out of fuel. N Engl J Med. 2007;356:1140-1151. (Pubitemid 46425598)
10. Schroeder MA, Atherton HJ, Ball DR, Cole MA, Heather LC, Griffin JL, Clarke K, Radda GK, Tyler DJ. Real-time assessment of Krebs cycle metabolism using hyperpolarized 13C magnetic resonance spectroscopy. FASEB J. 2009;23:2529-2538.
11. Ardenkjaer-Larsen JH, Fridlund B, Gram A, Hansson G, Hansson L, Lerche MH, Servin R, Thaning M, Golman K. Increase in signal-to-noise ratio of >10, 000 times in liquid-state NMR. Proc Natl Acad Sci U S A. 2003;100:10158-10163. (Pubitemid 37071849)
12. Golman K, in 't Zandt R, Thaning M. Real-time metabolic imaging. Proc Natl Acad Sci U S A. 2006;103:11270-11275. (Pubitemid 44156508)
13. Abbas AS, Wu G, Schulz H. Carnitine acetyltransferase is not a cytosolic enzyme in rat heart and therefore cannot function in the energy-linked regulation of cardiac fatty acid oxidation. J Mol Cell Cardiol. 1998;30: 1305-1309. (Pubitemid 28345032)
14. Friedman S, Fraenkel G. Reversible enzymatic acetylation of carnitine. Arch Biochem Biophys. 1955;59:491-501.
15. Pearson DJ, Tubbs PK. Carnitine and derivatives in rat tissues. Biochem J. 1967;105:953-963.
16. Renstrom B, Liedtke AJ, Nellis SH. Mechanisms of substrate preference for oxidative metabolism during early myocardial reperfusion. Am J Physiol. 1990;259:H317-H323. (Pubitemid 20259405)
17. Fritz IB, Schultz SK, Srere PA. Properties of partially purified carnitine acetyltransferase. J Biol Chem. 1963;238:2509-2517.
18. Lysiak W, Lilly K, DiLisa F, Toth PP, Bieber LL. Quantitation of the effect of l-carnitine on the levels of acid-soluble short-chain acyl-CoA and coASH in rat heart and liver mitochondria. J Biol Chem. 1988;263: 1151-1156. (Pubitemid 18039914)
19. Fritz IB, Yue KT. Effects of carnitine on acetyl-CoA oxidation by heart muscle mitochondria. Am J Physiol. 1964;206:531-535.
20. Saddik M, Gamble J, Witters LA, Lopaschuk GD. Acetyl-CoA carboxylase regulation of fatty acid oxidation in the heart. J Biol Chem. 1993;268:25836-25845. (Pubitemid 23358202)
21. Paulson DJ. Carnitine deficiency-induced cardiomyopathy. Mol Cell Biochem. 1998;180:33-41. (Pubitemid 28118801)
22. Waber LJ, Valle D, Neill C, DiMauro S, Shug A. Carnitine deficiency presenting as familial cardiomyopathy: a treatable defect in carnitine transport. J Pediatr. 1982;101:700-705.
23. Reibel DK, Uboh CE, Kent RL. Altered coenzyme A and carnitine metabolism in pressure-overload hypertrophied hearts. Am J Physiol.1983;244:H839-H843. (Pubitemid 13066970)
24. Schonekess BO, Allard MF, Lopaschuk GD. Propionyl l-carnitine improvement of hypertrophied heart function is accompanied by an increase in carbohydrate oxidation. Circ Res. 1995;77:726-734.
25. Lysiak W, Toth PP, Suelter CH, Bieber LL. Quantitation of the efflux of acylcarnitines from rat-heart, brain, and liver-mitochondria. J Biol Chem. 1986;261:3698-3703.
26. Schroeder MA, Clarke K, Neubauer S, Tyler DJ. Hyperpolarized magnetic resonance: a novel technique for the in vivo assessment of cardiovascular disease. Circulation. 2011;124:1580-1594.
27. Freeman R. Shaped radiofrequency pulses in high resolution NMR. Progr NMR Spectr. 1998;32:59-106. (Pubitemid 128405956)
28. Jensen PR, Peitersen T, Karlsson M, In 't Zandt R, Gisselsson A, Hansson G, Meier S, Lerche MH. Tissue-specific short chain fatty acid metabolism and slow metabolic recovery after ischemia from hyperpolarized NMR in vivo. J Biol Chem. 2009;284:36077-36082.
29. Schroeder M, Cochlin L, Heather L, Clarke K, Radda G, Tyler D. In vivo assessment of pyruvate dehydrogenase flux in the heart using hyperpolarized carbon-13 magnetic resonance. Proc Natl Acad Sci U S A. 2008; 105:12051-12056.
30. Tyler D, Schroeder M, Cochlin L, Clarke K, Radda G. The application of hyperpolarized magnetic resonance in the study of cardiac metabolism. Appl Magn Reson. 2008;34:523-531.
31. Naressi A, Couturier C, Castang I, de Beer R, Graveron-Demilly D. Java-based graphical user interface for MRUI, a software package for quantitation of in vivo/medical magnetic resonance spectroscopy signals. Comput Biol Med. 2001;31:269-286. (Pubitemid 32378728)
32. Atherton HJ, Dodd MS, Heather LC, Schroeder MA, Griffin JL, Radda GK, Clarke K, Tyler DJ. Role of pyruvate dehydrogenase inhibition in the development of hypertrophy in the hyperthyroid rat heart: a combined magnetic resonance imaging and hyperpolarized magnetic resonance spectroscopy study. Circulation. 2011;123:2552-2561.
33. Atherton HJ, Schroeder MA, Dodd MS, Heather LC, Carter EE, Cochlin LE, Nagel S, Sibson NR, Radda GK, Clarke K, Tyler DJ. Validation of the in vivo assessment of pyruvate dehydrogenase activity using hyperpolarised 13C MRS. NMR Biomed. 2011;24:201-208.
34. Zierhut ML, Yen YF, Chen AP, Bok R, Albers MJ, Zhang V, Tropp J, Park I, Vigneron DB, Kurhanewicz J, Hurd RE, Nelson SJ. Kinetic modeling of hyperpolarized 13C1-pyruvate metabolism in normal rats and TRAMP mice. J Magn Reson. 2010;202:85-92.
35. Marquis NR, Fritz IB. The distribution of carnitine, acetylcarnitine, and carnitine acetyltransferase in rat tissues. J Biol Chem. 1965;240: 2193-2196.
36. Grizard G, Lombard-Vignon N, Boucher D. Changes in carnitine and acetylcarnitine in human semen during cryopreservation. Hum Reprod. 1992;7:1245-1248.
37. O'Donnell JM, Zampino M, Alpert NM, Fasano MJ, Geenen DL, Lewandowski ED. Accelerated triacylglycerol turnover kinetics in hearts of diabetic rats include evidence for compartmented lipid storage. Am J Physiol. 2006;290:E448-E455. (Pubitemid 43671690)
38. Lewandowski ED, Damico LA, White LT, Yu X. Cardiac responses to induced lactate oxidation: NMR analysis of metabolic equilibria. Am J Physiol. 1995;269:H160-H168.
39. Sharma N, Okere IC, Brunengraber DZ, McElfresh TA, King KL, Sterk JP, Huang H, Chandler MP, Stanley WC. Regulation of pyruvate dehydrogenase activity and citric acid cycle intermediates during high cardiac power generation. J Physiol. 2005;562:593-603.
40. O'Donnell JM, Kudej RK, LaNoue KF, Vatner SF, Lewandowski ED. Limited transfer of cytosolic NADH into mitochondria at high cardiac workload. Am J Physiol Heart Circ Physiol. 2004;286:H2237-H2242. (Pubitemid 38685238)
41. Shigenaga MK, Hagen TM, Ames BN. Oxidative damage and mitochondrial decay in aging. Proc Natl Acad Sci U S A. 1994;91: 10771-10778. (Pubitemid 24349567)
42. Pierpont ME, Foker JE, Pierpont GL. Myocardial carnitine metabolism in congestive heart failure induced by incessant tachycardia. Basic Res Cardiol. 1993;88:362-370. (Pubitemid 23301329)